申请人:Hoffmann-La Roche Inc.
公开号:US04003914A1
公开(公告)日:1977-01-18
A novel class of dithiane and disulfone compound is described. These compounds are pharmaceutically active as coronary dilating agents and thus can be used therapeutically in cases of insufficient cardiac blood supply, i.e., in the treatment of angina pectoris. A preferred compound is N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)-N-methyl-m-dithiane-2-p ropylamine-1,1-3,3-tetraoxide.
一种新颖的二噻烷和二硫磺酮化合物被描述。这些化合物在药理学上作为冠状动脉扩张剂具有药效活性,因此可以在心脏血液供应不足的情况下进行治疗,即治疗心绞痛。首选的化合物是N-(3,4-二甲氧基苯乙基)-2-(3,4-二甲氧基苯基)-N-甲基-m-二噻烷-2-丙胺-1,1-3,3-四氧化物。